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BACKGROUND
Radical resection for recurrent cholangiocellular carcinoma
(CCC) is rare, with three metachronous radical resections re-
ported to date in only two patients. Both patients underwent major
hepatectomy twice after pancreatoduodenectomy (PD) for me-
tachronous CCC (1). The recurrence rate after radical resection
(R0) of intrahepatic cholangiocellular carcinoma (IHCC) is 50%-
80%, with the rate of second resection being only 11% (2). Liver
metastasis after initial resection of lower bile duct cancer has been
reported in 9%-45% of patients, with the rate of second resection,
including hepatectomy, being only 10% (3). Furthermore, only
2.1% of patients undergo complete radical hepatectomy for liver
metastasis after PD (4). This report describes a patient who under-
went repeated resections with curative intent of CCC after PD for
cancer of the middle bile duct.
CASE PRESENTATION
A 60 year old male underwent a distal gastrectomy for a duodenal
ulcer perforation in 23 years ago. After 3 years, he underwent PD
(Honjo method, Fig. 1) for middle bile duct cancer, pathologically
diagnosed as a papillary adenocarcinoma, at another hospital, and
was regularly followed-up at a local clinic.
After 8 years from primary resection, abdominal ultrasonogra-
phy and abdominal computed tomography showed a hepatic tumor,
and he was referred to our hospital for further examination.
Laboratory data at our institute are shown in Table 1. Multi -detector
CT showed a solitary tumor in S6 ; its edge was enhanced from
early phase, whereas its internal portion was gradually enhanced
(Fig. 2). Enhanced-MRI showed a low intensity lesion on T1- and
SPIO (superparamanager iron oxide)T1-weighted images, and a
high intensity lesion onT2-and diffusion-weighted images (Fig. 3).
The patient was diagnosed with IHCC and underwent subseg-
mentecomy (S6, Fig. 1) in 12 years ago. Because the patient had un-
dergone two previous abdominal operations, the operation time
was relatively long (6 hours and 7 minutes) due to strong adhe-
sions. Total bleeding during surgery was 140 ml.
The resected tumor was 4.0 × 2.5 cm in size. The edges of the
tumor were clear, with its center showing extensive necrosis.
Histopathologically, the tumor was diagnosed as a poorly differenti-
ated CCC (mass forming type, 4.0 × 2.5 cm, s0, vp0, vv0, va0, b0, sm
(-), pT2 N0 M0 fStage II ; Fig. 1, 4). It was considered a secondary
primary cancer. Despite our strong recommendations, the patient
refused adjuvant chemotherapy.
During follow-up as an outpatient, repeated cholangitis was ob-
served, and CT revealed the extension of the right intrahepatic bile
duct caused by hilar mass formation. Vessel invasions were sus-
pected in the right hepatic artery and right portal vein (Fig. 5).
Laboratory data at the second admission are shown in Table 1.
Percutaneous transhepatic biliary drainage (PTBD) was per-
formed, showing that the right hepatic bile duct was interrupted
and stenotic (Fig. 6). He was diagnosed with hilar cholangioma and
underwent right lobectomy of the liver and a repeat hepaticojejunos-
tomy (8 hours and 16minutes) in 6 years ago. Intraoperative find-
ings were shown in Fig. 7. The caudate lobectomy was not under-
gone considering operative invasiveness and liver functional vol-
ume after safety margins of the bile duct were guaranteed by the
diagnosis of frozen sections. Surgery was performed safely (total
bleeding, 380 ml), despite difficulties caused by severe adhesions
and re-anastomosis.
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Pathological examination of the resected specimen revealed a
well -differentiated CCC, considered the third primary tumor (in-
traductal growth type, s0, vp0, vv0, va0, im(-) sm(-), T2 N0 M0
fStage II ; Fig. 8). Despite our strong recommendation, the patient
refused adjuvant therapy. He survived without metastasis or recur-
rence after the operation, however, 28 months after surgery, lung
metastases were found and partial lung resection was performed.
Histological examination of the specimen showed the same fea-
tures, indicating a further metastasis of the previous hilar bile duct
cancer.
DISCUSSION
Duplicated cancers has been defined as malignant tumors occu-
pying sites distant from each other, with one not derived from the
other tumor (5). In addition, duplicated cancers generally occur
within one year (3). In our patient, the histological types of the three
tumors differed, they occurred in different locations, and the times
between occurrence were longer than one year each. Thus, these
tumors can be diagnosed as metachronous triple biliary cancer.
Tumors that recur after resection of biliary tract cancers are
often unresectable ; these include multiple organ and distant
lymph node metastases, as well as perivascular nerve plexus inva-
sion. Recurrences are considered resectable when localized, but
the effects of aggressive resection of CCC recurrence remain un-
clear. Repeated radical resections for metachronous biliary tract
cancers after hepatectomy are extremely rare. To date, simultane-
ous occurrence of metachronial triple biliary cancer has been re-
ported in only one patient (6), whereas metachronous occurrence
has not been observed. Furthermore, to our knowledge, only two
patients have undergone two or more liver resections after PD
(1, 7). Liver resection for recurrent biliary tract cancer has been
reported to significantly improve patient prognosis (14-16). One
study described surgical resection for recurrent biliary tract cancer
in 74 (12.2%) of 606 patients, including three patients who under-
went PD for local recurrence, 24 who underwent hepatic resection
for liver metastasis, and 23 who underwent resection for chest or
abdominal wall metastasis (8). The three-year overall survival rate
was significantly higher in patients who did than did not undergo
surgical resection (32.0% vs 3.0% ; P0.001). Furthermore, surgical
resection for recurrent CCC was an independent prognostic factor
for overall survival after recurrence (8). Although resection is the
most effective treatment, if possible, chemotherapeutic agents,
Table 1. Laboratory data in our hospital.
First admission Second admission
AST(IU/l) 23 53
ALT(IU/l) 19 36
T-Bil (mg/dl) 0.7 0.8
ALP(IU/l) 391 405
γ -GTP(IU/l) 66 126
AMY(IU/l) 65 65
CEA(ng/ml) 1.3 1.5
CA19-9(U/ml) 5 11
AFP(ng/ml) 5 12
DCP(mAU/ml) 17 34
Span-1(U/ml) 30 30
DUPAN-2(U/ml) 25 25
Fig. 1 Illustrations of the past surgical resections for metachronous triple biliary tract cancer. (a) Pancreatoduodenectomy (Honjo method) (b) S6
subsegmentectomy (c) Right lobectomy + reconstruction of left hepatico - jejunostomy.
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including gemcitabine, cisplatin, and tegafur-gimeracil -oteracil
potassium (TS-1), have been shown successful results in patients
with unresectable recurrent biliary tract cancers(9-12).
The combination of resection and chemotherapy may be a
powerful option in the treatment of patients with recurrent tumors.
For example, neoadjuvant or adjuvant GFP (gemcitabine, low dose
cisplatin, and 5-fluorouracil) has been shown effective in patients
with bile duct cancer (13). Our treatment algorithm for patients
with bile duct cancers therefore consists of R0 surgical resection
after GFP treatment, whether the tumor is curable or not.
In this time, we did not undergo the caudate lobectomy. For
perihilar cholangiocarcinoma, the major lobectomy with the cau-
date lobectomy is generally planned (19), however, there were
some reports that caudate lobectomy was not related to the
Fig. 2 Abdominal dynamic CT of our patient ; (a) early phase (b) portal phase (c) and late phase. The edges of the tumor were enhanced
during early phase, whereas the internal area was slightly enhanced during portal and late phases.
Fig. 3 Enhanced MRI, showed the tumor as a low intensity lesion on T1- (a) and SPIO T1-weighted (c : arrow) images, and as a high
intensity lesion on T2- (b) and diffusion-we ighted (d : arrowhead) images.
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prognosis considering the remnant liver volume, cancer margin of
the bile duct and operative invasiveness (20, 21). In this case, we
judged that caudate lobectomy was not suitable when we evaluated
the patient’s intraoperative findings and preoperative liver function
volume.
Repeated radical resection for CCC is extremely rare. There are
some reasons that make the repeated surgery difficult, one of
which would be the tumor factors such as location, the number of
tumor and the size, especially the anatomical changes resulting
from the intensive procedure performed at the previous resection.
In metachronous of biliary tract cancer, the clear evidence was
not demonstrated so far. There are some reports which insisted the
advantages of the resection by showing the long-term survival
after repeated operation (17, 18). Aggressive resection is therefore
an option for patients with repeated CCC.
CONCLUSIONS
In conclusion, we have experienced the long-term survival case
repeated radical resections for metachronous biliary tract can-
cers after hepatectomy. Aggressive resection is an option for pa-
tients with recurrent CCC.
CONSENT
Written informed consent was obtained from the patient for
publication of this case report and any accompanying images. A
copy of the written consent is available for review by the Editor of
this journal.
ABBREVIATIONS
AFP : α - fetoprotein
AMY : amylase
Fig. 5 Abdominal dynamic CT showing mass formations along the hilar bile duct. Marginally enhanced masses were observed during the
arterial (a) and portal (b,d) phases, but were attenuated during the venous phase (c). Hilar lesions suggested invasion of the posterior
segmental branch of the hepaticartery(a)and theright primary branch of the portal vein (b), but the hepatic vein was intact (c).
Fig. 4 Specimen obtained following subsegmentectomy of the liver,
showing a poorly differentiated tumor : 4×2.5 cm, s0, vp0, vv0, va0, im
( -), sm (-).
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ALP : alkaline phosphatase
ALT : alanine aminotransferase
AST : aspartate aminotransferase
CA19-9 : carbohydrate antigen 19-9
CEA : carcinoembryonic antigen
DCP : des-γ -carboxy prothrombin
DUPAN-2 : pancreas cancer-associated antigen-2
T-Bil : total bilirubin
γ -GTP : γ -glutamyltranspeptidase
Fig. 6 Percutaneous transhepatic biliary drainage (PTBD), showing
interruption and stenosis (arrowheads)of the right hepatic duct.
Fig. 8 Specimen obtained following right lobectomy of the liver
(Ig, s0, vp0, vv0, va0, im ( -), sm (-). The pathological type was well -
differentiated adenocarcinoma, differing from the pathological type of
the previous tumor(Fig. 4).
Fig. 7 Intraoperative findings in secondary reconstruction of the biliary tract. Severe adhesion around the ρ - loop (a). Detachment between right
hepatic artery(RHA)/right portal vein(RPV)and tumor(b). Intrahepatic cholangiojejunostomy(plasty of B2 and B3+4)(c).
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